- Home
- IKT vs TAYD Comparison
IKT vs TAYD Comparison
Compare IKT & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- TAYD
- Stock Information
- Founded
- IKT 2008
- TAYD 1955
- Country
- IKT United States
- TAYD United States
- Employees
- IKT N/A
- TAYD N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- TAYD Industrial Machinery/Components
- Sector
- IKT Health Care
- TAYD Industrials
- Exchange
- IKT Nasdaq
- TAYD Nasdaq
- Market Cap
- IKT 140.5M
- TAYD 154.2M
- IPO Year
- IKT 2020
- TAYD N/A
- Fundamental
- Price
- IKT $1.56
- TAYD $47.00
- Analyst Decision
- IKT Buy
- TAYD
- Analyst Count
- IKT 2
- TAYD 0
- Target Price
- IKT $8.00
- TAYD N/A
- AVG Volume (30 Days)
- IKT 92.1K
- TAYD 8.6K
- Earning Date
- IKT 11-13-2025
- TAYD 09-26-2025
- Dividend Yield
- IKT N/A
- TAYD N/A
- EPS Growth
- IKT N/A
- TAYD 11.24
- EPS
- IKT N/A
- TAYD 2.87
- Revenue
- IKT N/A
- TAYD $46,292,725.00
- Revenue This Year
- IKT N/A
- TAYD $10.81
- Revenue Next Year
- IKT N/A
- TAYD $8.37
- P/E Ratio
- IKT N/A
- TAYD $16.45
- Revenue Growth
- IKT N/A
- TAYD 3.83
- 52 Week Low
- IKT $1.12
- TAYD $29.50
- 52 Week High
- IKT $4.20
- TAYD $64.50
- Technical
- Relative Strength Index (RSI)
- IKT 42.51
- TAYD 50.82
- Support Level
- IKT $1.50
- TAYD $44.00
- Resistance Level
- IKT $1.73
- TAYD $48.61
- Average True Range (ATR)
- IKT 0.09
- TAYD 1.73
- MACD
- IKT -0.02
- TAYD -0.26
- Stochastic Oscillator
- IKT 17.34
- TAYD 43.17
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About TAYD Taylor Devices Inc.
Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.